Report of autochthonous cases of localized cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana in vulnerable, susceptible areas of Southeastern Mexico

• Published in: Revista do Instituto de Medicina Tropical de São Paulo 2022, Vol.64, p.e35-8
• Main Authors: Canché-Pool, Elsy Beatriz, Canto-Hau, Dulce María, Vargas-Meléndez, Mirna Alexandra, Tello-Martín, Raúl, Reyes-Novelo, Enrique, Escobedo-Ortegón, Francisco Javier, Ruiz-Piña, Hugo Antonio, Cambranes-Puc, Luis Humberto, Torres-Castro, Jimmy Raymundo, Palacio-Vargas, Jorge Alfredo, Durán-Caamal, Celmy, Cerón-Espinosa, José, Carpio-Pedroza, Juan Carlos, Rivera-Hernández, Octavio César
• Format: Article
• Language: English
• Subjects: Disease prevention; Original; Parasitic diseases; Patients; Tropical diseases; TROPICAL MEDICINE; Ulcers
• ISSN: 1678-9946; 0036-4665; 1678-9946
• DOI: 10.1590/S1678-9946202264035

Localized cutaneous leishmaniasis (LCL) is an endemic disease in several Mexican States with the main endemic areas located in the South-Southeast region of the country, where 90% of Leishmania (Leishmania) mexicana cases are registered. The Southeast region is located in the Yucatan Peninsula, including Campeche, Quintana Roo and Yucatan States. Campeche and Quintana Roo register more than 60% of the cases in the country each year, while in Yucatan the reports are of imported cases due to residents traveling to endemic areas. However, since 2015, autochthonous cases have been diagnosed by health authorities in municipalities with no previous transmission records. We aimed to identify Leishmania parasite species involved in autochthonous cases by means of the PCR technique. The present study included 13 autochthonous cases of LCL with clinical and parasitological diagnoses during 2018 and 2019 by health authorities, without specific identification of the causal agent. Tissue samples were taken by scraping the margins of active lesions and then they were spotted onto an FTATM Elute Microcard. Next, DNA was eluted and used for PCR amplification of specific Leishmania genus and L. (L.) mexicana species-specific fragments. Molecular analysis showed evidence that L. (L.) mexicana was the causal agent of LCL in 12 of the 13 patients; in one patient, PCR was not performed due to the patient's refusal to participate in the study. Identifying Leishmania species that cause LCL is necessary to define efficient treatment schemes and control strategies for the disease in vulnerable and susceptible areas of the Yucatan State's municipalities.